YugalinksStart free

T13 · Trade opportunity evidence

China (CHN) to MAR (MAR) blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale (HS6 300215)

A country-to-country view of reported blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale trade, combining buyer demand, exporter position, market structure, access conditions, and observed lane history.

Explore HS 300215 in the workspace
Exporter China (CHN)Importer MAR (MAR)HS6 300215Coverage 2012-2024Growing

3-year buyer projection

$195.9MCalculated from reported demand

Exporter growth

+12.7%Full available history

Suppliers in market

31Latest reported count

Observed history

13 yearsLast year: 2024

Reported observations

What this blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale lane shows for HS 300215

Core values for China (CHN) → MAR (MAR) in HS 300215.

Buyer market

Latest imports$147.4M
Five-year projection$236.9M
Buyer CAGR+9.9%
Latest annual change+14.1%

Exporter position

Latest exports$44.4K
Market share0%
Share change-0.1 pp
Best observed share49.9%

Market structure

Reported suppliers31
Concentration index2,903.7
Share gap+49.9 pp
SignalGrowing

Detailed evidence

Complete lane evidence

Reported values, calculated indicators, and country-pair context for this route.

MeasureValueWhat it describes
Buyer imports$147.4MMAR (MAR)'s latest reported imports
Exporter exports$44.4KChina (CHN)'s exports to MAR (MAR)
Exporter market share0%Exporter share of the reported buyer market
Buyer five-year CAGR+9.9%Annualized change in buyer imports
Exporter full-history CAGR+12.7%Annualized change in exporter exports
Three-year buyer projection$195.9MCalculated projection from reported demand
Five-year buyer projection$236.9MCalculated projection from reported demand
Average buyer imports$88.7MAverage reported importer value
Peak buyer imports$147.4MHighest reported importer value
Average exporter exports$227.1KAverage reported lane exports
Peak exporter exports$1.9MHighest reported lane exports
Share change-0.1 ppLatest one-year change in exporter share
Reported suppliers31Supplier countries observed in the latest period
Buyer GDP$132.7BLatest buyer-country GDP estimate
Buyer GDP per person$3.6KLatest buyer-country GDP per person
Buyer population37,344.8 thousandLatest buyer-country population estimate
Buyer investment rate32.8%Reported buyer-country investment rate
Buyer secondary education42%Reported secondary education coverage
Distance9,951 kmApproximate country-pair distance
Business entry time9 daysReported days to start a business
Shared legal systemNoCountry-pair institutional relationship
Reported FTANoReported trade-agreement indicator
WTO memberYesBuyer-country WTO membership indicator
Lane volatility2.2Variation indicator across observed lane values
Maximum drawdown98.2%Largest observed decline from a prior peak
Observed history13 yearsCoverage through 2024

Research reading

Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale demand and the China (CHN) to MAR (MAR) lane

MAR (MAR) reported $147.4M of blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale imports in 2024. China (CHN) accounted for 0% of the observed market and reported $44.4K in exports on this lane.

The latest annual values eased slightly, while the longer available history shows +9.9% buyer growth and +12.7% exporter growth. The page separates reported values from projections and indicators.

Product classification

What does HS 300215 include?

HS 300215 covers Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale. This page studies the six-digit Harmonized System classification rather than a company, brand, retail category, or individual shipment.

The classification sits in HS chapter 30 and heading 3002. The recorded trade type is not reported, with a not reported classification in the available product reference data.

How to interpret this page

Compare demand, position, and history together

This HS 300215 trade opportunity page brings together the buyer market in MAR (MAR), the exporter position of China (CHN), and the observed conditions of their trade lane. A large buyer market does not by itself show that every exporter has equal access, and a positive growth rate does not remove the need to examine volatility and historical coverage.

Use the reported imports and exports to understand scale, market share to understand position, projections to understand the calculated forward view, and lane history to understand how much evidence supports the comparison.

Frequently asked questions

Questions about China (CHN) to MAR (MAR) blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale trade

What is the HS code for this product?

This page covers HS 300215, the six-digit product classification shown in the trade records.

How large is the MAR (MAR) market?

The page reports the latest buyer imports, historical averages, peaks, growth, and calculated projections for blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale.

How strong is China (CHN) in this market?

Exporter performance is shown through lane exports, market share, share change, growth, and the number of reported suppliers.

What should be checked before entering this market?

Review market scale, competition, access indicators, volatility, drawdown, and the available history together rather than relying on one signal.

Continue your researchHS 300215 product overviewExplore this product in the workspaceMethodology and definitions

Definitions and coverage

How to read this page

Reported values

Trade values describe reported merchandise trade for the stated HS6 classification. They are not company-level sales or shipment records.

Calculated indicators

Growth, projections, concentration, volatility, and share-gap figures are calculated from the reported observations and should be interpreted with their coverage period.

Coverage

This sample covers 13 observed years through 2024. Missing values are shown as not reported rather than estimated.